News
Nuestro proyecto Cringenes es reconocido en los VI Premios Redacción Médica á Sanidade de Galicia
El Proyecto de cribaje genómico neonatal recibió el premio Acción Investigadora
Primer premio de Farma Impulso para el proyecto OPTIGUSEL
Se trata de un trabajo del grupo de investigación FarmaCHUSLab del IDIS
Participamos activamente en el Pint of Science 2026
El IDIS colaboró en la organización del festival en Brión, que su sumó por primera vez a esta cita, pero nuestro personal investigador participó en los eventos celebrados en diversas localidades
Calendar
COMMON SUPPORT PLATFORMS
The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.
CALLS
All updated information on public and private competitive calls. The most convenient and safest way to send your requests.
CAREERS
Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.
Research Areas
ONCOLOGY
Improvement of treatments: personalised therapy and reduction of side effects.
GENETICS AND SYSTEMS BIOLOGY
Identification of genetic biomarkers of disease susceptibility and prognosis
ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO
The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.
NEUROSCIENCES
Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.
CARDIOVASCULAR
The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.
PLATFORMS AND METODOLOGY
The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.
















